title: Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells.
abstract: The cardioprotective effects of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A1 (apoA-I) are well documented, but their effects in the direction of the cardiac differentiation of embryonic stem cells are unknown. We evaluated the effects of exogenous apoA-I expression on cardiac differentiation of ESCs and maturation of ESC-derived cardiomyocytes. We stably over-expressed full-length human apoA-I cDNA with lentivirus (LV)-mediated gene transfer in undifferentiated mouse ESCs and human induced pluripotent stem cells. Upon cardiac differentiation, we observed a significantly higher percentage of beating embryoid bodies, an increased number of cardiomyocytes as determined by flow cytometry, and expression of cardiac markers including α-myosin heavy chain, β-myosin heavy chain and myosin light chain 2 ventricular transcripts in LV-apoA-I transduced ESCs compared with control (LV-GFP). In the presence of noggin, a BMP4 antagonist, activation of BMP4-SMAD signaling cascade in apoA-I transduced ESCs completely abolished the apoA-I stimulated cardiac differentiation. Furthermore, co-application of recombinant apoA-I and BMP4 synergistically increased the percentage of beating EBs derived from untransduced D3 ESCs. These together suggests that that pro-cardiogenic apoA-I is mediated via the BMP4-SMAD signaling pathway. Functionally, cardiomyocytes derived from the apoA-I-transduced cells exhibited improved calcium handling properties in both non-caffeine and caffeine-induced calcium transient, suggesting that apoA-I plays a role in enhancing cardiac maturation. This increased cardiac differentiation and maturation has also been observed in human iPSCs, providing further evidence of the beneficial effects of apoA-I in promoting cardiac differentiation. In Conclusion, we present novel experimental evidence that apoA-I enhances cardiac differentiation of ESCs and iPSCs and promotes maturation of the calcium handling property of ESC-derived cardiomyocytes via the BMP4/SMAD signaling pathway.
authors: Stem Cell & Regenerative Medicine Program, Research Centre of Heart, Brain, Hormone and Healthy Ageing, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong.
authors: Kwong-Man
authors: KM
authors: Ng
authors: Yee-Ki
authors: YK
authors: Lee
authors: Wing-Hon
authors: WH
authors: Lai
authors: Yau-Chi
authors: YC
authors: Chan
authors: Man-Lung
authors: ML
authors: Fung
authors: Hung-Fat
authors: HF
authors: Tse
authors: Chung-Wah
authors: CW
authors: Siu
references: J Gen Physiol. 1968 Sep 1;52(3):666-81
references: 19873638
references: Nature. 2008 May 22;453(7194):524-8
references: 18432194
references: Stem Cells Dev. 2010 Nov;19(11):1723-34
references: 20412016
references: Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1793-803
references: 19363129
references: J Biochem. 2010 Jan;147(1):35-51
references: 19762341
references: Clin Transl Sci. 2008 Sep;1(2):116-25
references: 20443832
references: Nature. 1997 Dec 4;390(6659):465-71
references: 9393997
references: FEBS Lett. 2001 Nov 30;509(1):126-30
references: 11734219
references: Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H1022-8
references: 20061542
references: N Engl J Med. 1989 Nov 9;321(19):1311-6
references: 2677733
references: Curr Opin Investig Drugs. 2001 Sep;2(9):1235-6
references: 11717809
references: Genes Dev. 2005 Dec 1;19(23):2783-810
references: 16322555
references: Circulation. 2006 Sep 26;114(13):1403-9
references: 16982942
references: Circulation. 2008 Mar 25;117(12):1563-73
references: 18332268
references: Cardiovasc Res. 2010 Jan 1;85(1):118-26
references: 19700468
references: Immunol Lett. 1994 Sep;42(1-2):41-7
references: 7829128
references: Stem Cells. 2008 Aug;26(8):1961-72
references: 18483424
references: Circ Res. 2006 Jun 9;98(11):1352-64
references: 16763172
references: Trends Cardiovasc Med. 2003 Aug;13(6):226-31
references: 12922018
references: Reprod Toxicol. 2005 Sep-Oct;20(3):377-91
references: 15967632
references: Nat Rev Mol Cell Biol. 2007 Dec;8(12):970-82
references: 18000526
references: Growth Factors. 2004 Dec;22(4):233-41
references: 15621726
references: Cardiovasc Res. 2005 Jun 1;66(3):482-92
references: 15914113
references: Stem Cells. 2007 Dec;25(12):3038-44
references: 17872499
references: Am J Physiol Cell Physiol. 2009 Jul;297(1):C152-9
references: 19357236
references: Stem Cells Dev. 2009 Dec;18(10):1493-500
references: 19290776
references: Genes Dev. 1995 Sep 1;9(17):2105-16
references: 7657163
references: Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2266-74
references: 18948634
references: Circ Res. 2004 Oct 15;95(8):764-72
references: 15486323
references: In Vitro Cell Dev Biol Anim. 2009 Oct;45(9):566-72
references: 19585175
references: Int J Cardiol. 2007 Aug 9;120(1):92-101
references: 17156864
references: Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):343-55
references: 19897402
references: Circ Res. 1994 Aug;75(2):233-44
references: 8033337
references: Biochem Biophys Res Commun. 2009 Feb 20;379(4):898-903
references: 19135029
references: Int J Cardiol. 2008 Jun 23;127(1):78-87
references: 17714812
references: J Mol Cell Cardiol. 2010 Jun;48(6):1129-37
references: 20116384
references: Heart Rhythm. 2010 Dec;7(12):1852-9
references: 20833268
references: Cardiovasc Hematol Disord Drug Targets. 2007 Jun;7(2):145-52
references: 17584049
references: Biochem J. 2006 May 15;396(1):e1-3
references: 16626281
references: Biochemistry. 1985 Jul 30;24(16):4450-5
references: 3931677
references: Development. 1999 Apr;126(8):1571-80
references: 10079220
references: FEBS Lett. 2004 Jan 16;557(1-3):39-44
references: 14741338
references: Dev Biol. 2002 May 15;245(2):291-303
references: 11977982
references: Mol Endocrinol. 2010 Sep;24(9):1728-36
references: 20667986
references: Biochem Biophys Res Commun. 2008 Dec 12;377(2):413-418
references: 18930709